Queen Elizabeth II Health Science Centre

Halifax, Nova Scotia B3H2Y9

0 studies enrolling now · 10 studies all time

What they study most

Acute Myocardial Infarction, Congestive Heart Failure, Deep Vein Thrombosis, Diffuse Large B-cell Lymphoma, Ischemic Stroke, Mantle-Cell Lymphoma, Multiple Myeloma, Pancreatic Cancer, Pregnancy, Renal Cell Cancer, ST-Elevation Myocardial Infarction, Stroke, Acute

Studies at this site

• Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL — Running, not enrolling
• Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL) — Completed
• Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis — Completed
• IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction — Completed
• Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients — Completed
• Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke — Completed
• Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer — Completed
• Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer — Status unconfirmed
• Albumin in Acute Ischemic Stroke Trial — Stopped early
• A Study of ABT-751 in Patients With Renal Cell Cancer — Completed